Concepedia

Brian Everatt

BE

Statistics

Publications

9

Citations

239

H-Index

9

Active since

1987

Affiliations

Novartis (United Kingdom)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Royal Society for the Prevention of Cruelty to Animals

Novartis (United States)

Brian Everatt is an author at Novartis (United Kingdom) specializing in pharmacology, medicinal chemistry, and analytical chemistry.

Publications per year

1987–2021

9

Publications

9

Novel zwitterionic polyphosphorylcholine monolithic column for hydrophilic interaction chromatography

Zhengjin Jiang, John Reilly, Brian Everatt et al. · Journal of Chromatography A · 2009 · 82 citations

, , +6

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Darren Le Grand, Martin Gosling, Urs Baettig et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

, , +17

A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands

Zhengjin Jiang, John Reilly, Brian Everatt et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 28 citations

, , +15

Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases

David A. Sandham, Nicola Arnold, Heinrich Aschauer et al. · Bioorganic & Medicinal Chemistry · 2013 · 22 citations · Full text

, , +9

2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists

David A. Sandham, Clive Aldcroft, Urs Baettig et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 18 citations · Full text

, , +9

1–5 of 9